BDENZA (Enzalutamide)-40mg

BDENZA (Enzalutamide) is a nonsteroidal antiandrogen (NSAA). It works by impeding the impacts of androgen (a male regenerative hormone) to stop the development and spread of malignant growth cells.

It is used for the treatment of metastatic, castration-resistant prostate cancer (MCRPC).

Enquiry Now

Additional information

Trade Name

BDENZA 40mg

Generic Name

Enzalutamide

Manufacturer

BD

Drug Type

Oncology

Indication

Prostate cancer

Doasage Form

Capsules

Packaging

4 X 28 Capsules